Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Gilead Not Bullet-Proof After All: Harvoni US Sales Tumble More Than 50%
Apr 28 2016
•
By
Joseph Haas
More from Business
More from Scrip